Cytokinetics reported $-107033000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -30360000 2.78M
Amgen AMGN:US USD 3.04B 460M
Arca Biopharma ABIO:US USD -5675000 1.58M
Bayer BAYN:GR EUR 2.45B 2.31B
Biogen BIIB:US USD 992.8M 82.9M
Brainstorm Cell Therapeutics BCLI:US USD -6771000 749K
Bristol Myers Squibb BMY:US USD 4.66B 663M
Cytokinetics CYTK:US USD -107033000 97.57M
Exelixis EXEL:US USD 88.28M 206K
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Intra Cellular Therapies ITCI:US USD -55459000 32.29M
Novartis NOVN:VX USD 4.5B 193M
Pfizer PFE:US USD 6.94B 3.94B
Roche Holding ROG:VX 13.44B 2.56B